A Biomarker-implemented Clinical Study Evaluating Mutations in MET and TP53 in a Population of Treatment-refractory Squamous Cell Carcinoma
Clinical trial NCT04533321 · UNKNOWN
Trial details
- NCT number
- NCT04533321
- Sponsor
- National University Hospital, Singapore
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-01
- Primary completion
- 2023-09-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.